These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37978019)

  • 1. Risk factors and mortality of SARS-CoV-2 reinfection during the Omicron era in Taiwan: A nationwide population-based cohort study.
    Chen YH; Lee CY; Cheng HY; Chen CM; Cheuh YN; Lee CL; Kuo HW
    J Microbiol Immunol Infect; 2024 Feb; 57(1):30-37. PubMed ID: 37978019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022.
    Vicentini M; Venturelli F; Mancuso P; Bisaccia E; Zerbini A; Massari M; Cossarizza A; De Biasi S; Pezzotti P; Bedeschi E; Giorgi Rossi P; ;
    Euro Surveill; 2023 Mar; 28(13):. PubMed ID: 36995374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
    Cegolon L; Magnano G; Negro C; Larese Filon F;
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 immune response and reinfection in vaccinated Maya and mestizo in Southeast of Mexico.
    Monteón V; León-Pérez F; Ancona-León JG; Gutiérrez-Torres G
    Salud Publica Mex; 2023 Dec; 66(1, ene-feb):14-16. PubMed ID: 38065105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China.
    Yu W; Guo Y; Hu T; Liu Y; Fan Q; Guo L; Zheng B; Kong Y; Zhu H; Yu J; Chen S; Zhang Y; Wang J; Li F; Yang F; Wang Y; Zhu Y; Huang Y; Shen Z; Ruan Y; Mao R; Zhang J
    J Med Virol; 2023 Aug; 95(8):e28997. PubMed ID: 37537950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
    Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
    BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis.
    Ismail NF; Rahman AE; Kulkarni D; Zhu F; Wang X; Del Carmen Morales G; Srivastava A; Allen KE; Spinardi J; Kyaw MH; Nair H
    J Glob Health; 2023 Nov; 13():06051. PubMed ID: 37994839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study.
    Flacco ME; Soldato G; Acuti Martellucci C; Di Martino G; Carota R; Caponetti A; Manzoli L
    Front Public Health; 2022; 10():884121. PubMed ID: 35586006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The symptoms and interval of Omicron SARS-CoV-2 reinfection among healthcare workers in a hospital of Southern China: a cross-sectional study.
    Ma X; Wang Z; Chen Y; Li Z
    BMC Infect Dis; 2024 Mar; 24(1):354. PubMed ID: 38539124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent symptomatic Omicron infection reduced COVID-19 pneumonia risk during reinfection: A computed tomography-based cohort study.
    Zheng Y; Jia S; Tang L; Yu L; Yang X; Yang S; Ke Q; Cheng Z; Zhu Y; Chen H; Hong P
    Int J Infect Dis; 2024 Sep; 146():107164. PubMed ID: 38969328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023.
    Zhang M; Cao L; Zhang L; Li X; Chen S; Zhang Y
    BMC Public Health; 2024 Feb; 24(1):496. PubMed ID: 38365671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection.
    Lewis N; Chambers LC; Chu HT; Fortnam T; De Vito R; Gargano LM; Chan PA; McDonald J; Hogan JW
    JAMA Netw Open; 2022 Jul; 5(7):e2223917. PubMed ID: 35895058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant Rise in SARS-CoV-2 Reinfection Rate in Vaccinated Hospital Workers during the Omicron Wave: A Prospective Cohort Study.
    Ochoa-Hein E; Leal-Morán PE; Nava-Guzmán KA; Vargas-Fernández AT; Vargas-Fernández JF; Díaz-Rodríguez F; Rayas-Bernal JA; González-González R; Vázquez-González P; Huertas-Jiménez MA; Rajme-López S; Ramos-Cervantes P; Ibarra-González V; García-Andrade LA; Ledesma-Barrientos F; Ponce-de-León A; Sifuentes-Osornio J; Galindo-Fraga A
    Rev Invest Clin; 2022; 74(4):175-180. PubMed ID: 36087938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Omicron Variant Reinfection and Reduction of Reinfection Risk After Coronavirus Disease 2019 Vaccination in Children.
    Ikuse T; Aizawa Y; Hasegawa S; Takahashi M; Hayashi T; Kon M; Tamura T; Matsumoto H; Saitoh A
    J Pediatric Infect Dis Soc; 2023 Dec; 12(12):634-637. PubMed ID: 37936292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province.
    Wang Y; Liang J; Yang H; Zhu L; Hu J; Xiao L; Huang Y; Dong Y; Wu C; Zhang J; Zhou X
    Front Public Health; 2023; 11():1256768. PubMed ID: 37780420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants.
    Özüdoğru O; Bahçe YG; Acer Ö
    Ir J Med Sci; 2023 Apr; 192(2):751-756. PubMed ID: 35711013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study.
    Jang EJ; Choe YJ; Yun GW; Wang S; Cho UJ; Yi S; Lee S; Park YJ
    J Med Virol; 2022 Nov; 94(11):5589-5592. PubMed ID: 35879105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A follow-up study on the recovery and reinfection of Omicron COVID-19 patients in Shanghai, China.
    Lin M; Cao K; Xu F; Wu X; Shen Y; Lu S; Kuang Z; Ding H; Yuan S; Shao M; Gu G; Xing L; Gu T; Chen S; Sun J; Zhu J; Zhang X; Yang Y; Zhao G; Huang L; Xu J; Song Z
    Emerg Microbes Infect; 2023 Dec; 12(2):2261559. PubMed ID: 37732336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.